1 result(s) for
|PI Name||Protocol #||Title|
|Laura Newell||STUDY00020531||A Phase 1b trial of CPX-351 Lower Intensity Therapy (LIT) plus Venetoclax as First Line Treatment for Subjects with AML who are Unfit for Intensive Chemotherapy|
You may also qualify for Phase 1 Program trials.
For more information: